Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Nickkholgh, A; Frey, E; Krenzel, C; Lauchart, W; Flechtenmacher, C; Schmidt, J; Schemmer, P.
The need for vigilance in extended criteria donors with a past history of malignancy: a case report and review of literature.
Ann Transplant. 2011; 16(1):75-79
(- Case Report)
Web of Science
PubMed
- Führende Autor*innen der Med Uni Graz
- Schemmer Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- Organ shortage has prompted many transplant centers to extend their criteria for organ acceptance including the history of a variety of co-morbidities in donors. The use of organs from donors with a past medical history of malignancy in order to reduce the waiting list mortalities remains a dilemma. Herein we report a 62-year-old female donor with a history of a presumably cured serous adenocarcinoma of the ovary and underscore the need for vigilance in the search of an active site of cancer while assessing these donors for organ recovery. In order to minimize the risk of donor tumor transmission, especially in the donors with a past medical history of cancer, extensive evaluation of the donor including the surgical exploration of all body cavities is absolutely necessary. Any suspicious lesion should prompt a frozen section biopsy. In this regard, an on-call pathologist to do the frozen section should be an integral part of the transplant team.
- Find related publications in this database (using NLM MeSH Indexing)
- Cystadenocarcinoma, Serous - pathology
- Donor Selection - methods
- Female -
- Humans -
- Middle Aged -
- Neoplasm Recurrence, Local - pathology
- Neoplasms - prevention & control
- Ovarian Neoplasms - pathology
- Risk Factors -
- Tissue Donors -
- Tissue and Organ Harvesting -
- Transplants - adverse effects
- Find related publications in this database (Keywords)
- extended criteria donor
- liver transplantation
- donor malignancy
- serous adenocarcinoma of the ovary